Licensing and Accreditation
All MAWD laboratories are accredited by the College of American Pathologists (CAP) and certified pursuant to the Clinical Laboratory Improvement Amendments of 1988 (CLIA).
Emergency Use Authorizations
On October 13, 2023, the Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to MAWD Laboratories for its SARS-CoV-2 Dual Target by RT-PCR test. Patient and healthcare provider fact sheets are available at the links below.
Effective Date: 09/22/1995
Effective Date: 06/13/2003